Project Number 3R01CA236352-03S1 Agency/Funding Organization NCI Funding Year 2021 View Full Project Details for Pharmacological targeting of circadian clock components to treat glioblastoma Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 15. Sleep and Circadian Rhythm Researcher and Organization Principal Investigator PANDA, SATCHIDANANDA Principal Investigator First Name SATCHIDANANDA Principal Investigator Last Name PANDA Awardee Organization SALK INSTITUTE FOR BIOLOGICAL STUDIES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $475,000 Funding Organization Agency/Funding Organization NCI Funding Organization Country United States
